Unknown

Dataset Information

0

Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma.

ABSTRACT:

SUBMITTER: Diamond JR 

PROVIDER: S-EPMC3661938 | biostudies-literature | 2013 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma.

Diamond Jennifer R JR   Salgia Ravi R   Varella-Garcia Marileila M   Kanteti Rajani R   LoRusso Patricia M PM   Clark Jeffrey W JW   Xu Ling-Guo LG   Wilner Keith K   Eckhardt S Gail SG   Ching Keith A KA   Lira Maruja E ME   Schoenmakers Eric F P M EF   Christensen James G JG   Camidge D Ross DR  

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20130422 16

Similar Datasets

Unknown A Review of Papillary Renal Cell Carcinoma and MET Inhibitors.
| S-EPMC6918905 | biostudies-literature
Unknown MET Inhibition in Clear Cell Renal Cell Carcinoma.
| S-EPMC4934028 | biostudies-literature
Unknown Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer.
| S-EPMC5140694 | biostudies-literature
Unknown MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells.
| S-EPMC8059549 | biostudies-literature
Unknown Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON.
| S-EPMC9827108 | biostudies-literature
Unknown Inhibition of TFF3 Enhances Sensitivity-and Overcomes Acquired Resistance-to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma.
| S-EPMC6826976 | biostudies-literature
Genomics Renal papillary cell carcinoma
| PRJNA749556 | ENA
Unknown Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients.
| S-EPMC4670110 | biostudies-literature
Unknown Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
| S-EPMC5527443 | biostudies-literature
Transcriptomics Renal papillary cell carcinoma
2024-05-22 | GSE180777 | GEO